Gesa Albers – PhD Student
I graduated in 2017 with a MSc from Georg-August-University Goettingen in Germany and subsequently started my PhD at Imperial College in 2018. My PhD project focuses on glycolytic reprogramming in alveolar macrophages contributes during the pathogenesis of allergic airway diseases and investigates whether manipulating the metabolism of alveolar macrophages can be used as a novel therapeutic strategy to treat asthma. During my PhD, I aim to define metabolic signatures in asthmatic lungs using human patient samples as well as murine models of allergic airway disease. Here, I will test how exposure to allergen alters the metabolism of alveolar macrophages. In addition, I will investigate whether blocking different metabolic pathways affects the response to allergen. These findings will potentially help to develop new approaches to treat asthma by targeting the metabolism of alveolar macrophages.